P. Kelly (Dublin, Ireland), F. D. Mihaltan (Bucharest, Romania)
A case with new case multidrug resistant cranial and pulmonary tuberculosis successfully treated with major antituberculous drugs
B. Ciftci, M. Z. Guler, O. Konur, P. Kuli, Y. Erdogan (Ankara, Turkey)
|  |
Factors that effect sputum culture convertion rate in the patients with pulmonary TB who were applied directly observation therapy(DOT) and non-directly observation therapy
A. Uzundag Iseri, G. Dulkar, O. Selcuk Sonmez, L. Yilmaz Aydin (Ankara, Turkey)
| |
New approaches to treatment of HIV-associated tuberculosis in penitentiary institutions of Belarus
G. S. Avdeev, P. S. Kryvanos, V. N. Shamshur, A. F. Grinevich (Minsk, Belarus)
| |
Treatment of tuberculosis in Hungary in 2003
J. Mester, A. Somoskovi, I. Vadasz (Budapest, Hungary)
| |
Tuberculosis: follow-up of treatment without directed observed therapy (DOT) in a sanitary area
J. M. Garcia-Garcia, F. Alvarez-Navascues, Z. Bastardo, M. Sanchez-Fernandez, A. Sanchez-Antuna, M. Martinez-Muniz, M. Garcia-Marron, H. Villar, J. M. F.-Carreira (Aviles, Aviles. Asturias, Spain)
| |
Effects of complex treatment with izofon of a pulmonary tuberculosis in children
L. B. Yaroshchuk, V. P. Kostromina, E. A. Rechkina (Kiev, Ukraine)
| |
Development of new drug products for inhalation therapy of tuberculosis
M. I. Dziusmikeyeva, L. K. Surkova, A. M. Zalutskaya, H. L. Hurevich (Minsk, Belarus)
| |
Results of the treatment administered to the patients with pulmonary tuberculosis in Bucharest, 2002
C. D. Marica, C. Didilescu, V. Spanu (Bucharest, Romania)
| |
Re-treatment results of DOTS strategy in Iasi County, Romania
Z. E. Tarevici, C. I. Cojocaru, T. T. Mihaescu (Iasi, Romania)
| |
Approach of health workers and patients to directly observed therapy
S. Alptekin, M. Aydin, O. Ceyhan, I. Coskunol, S. Ayik (Izmir, Turkey)
| |
Isoniazid acetylation phenotype in a group of Tunisian patients (about 515 patients)
N. Mehiri, J. Cherif, B. Louzir, S. Fenna, S. B. Amira, M. Beji, J. Daghfous (Tunis, Tunisia)
| |
Treatment outcomes of tuberculosis patients under directly observed therapy (DOT) for three years
S. Arpaz, S. Keskin, N. Sezgin, D. Budin (Aydin, Turkey)
| |
Success of re-treatment regime and influencing factors in patients with tuberculosis
Z. Kilicaslan, F. Ozturk, N. Sarimurat, S. Kumbetli, C. Kucuk, D. Polat, E. Pekdemir (Istanbul, Turkey)
| |
Treatment effectiveness among patients with newly detected pulmonary tuberculosis with diabetes mellitus comorbidity
G. A. Smailova, G. L. Saguintaeva, S. S. Shaimuratov (Almaty, Kazakhstan)
| |
Different directly observed treatment observers and smear and culture conversions in tuberculosis
S. Arpaz, S. Keskin, N. Sezgin, D. Budin, S. Ozkara (Aydin, Ankara, Turkey)
| |
The validity of classic symptoms, medical history, and chest radiographs in predicting pulmonary tuberculosis (the TB scoring system)
F. G. Peleo, T. C. Atienza, T. O. Aquino (Diliman, Quezon City, The Philippines)
| |
The nephrotoxic effect assesment of tuberculostatic drugs therapy by urinary enzymes
L. M. Munteanu, D. M. Cocarla (Timisoara, Romania)
| |
How many sputum smears are necessary for case finding in pulmonary tuberculosis in a out-patient clinic?
A. Uysal, S. Altin, I. Tas (Istanbul, Turkey)
| |
Peculiarities of extrapulmonary tuberculosis in Siberia
E. V. Kulchavenya, V. V. Cernyshov (Novosibirsk, Russia)
| |